PSI Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-190
| Closed | -$6.22K | – | 618 |
|
|
2025
Q1 | $6.22K | Hold |
190
| – | – | ﹤0.01% | 512 |
|
|
2024
Q4 | $6.87K | Hold |
190
| – | – | ﹤0.01% | 581 |
|
|
2024
Q3 | $5.92K | Hold |
190
| – | – | ﹤0.01% | 634 |
|
|
2024
Q2 | $5.08K | Hold |
190
| – | – | ﹤0.01% | 639 |
|
|
2024
Q1 | $6.48K | Hold |
190
| – | – | ﹤0.01% | 552 |
|
|
2023
Q4 | $5.5K | Hold |
190
| – | – | ﹤0.01% | 609 |
|
|
2023
Q3 | $5.24K | Hold |
190
| – | – | ﹤0.01% | 585 |
|
|
2023
Q2 | $5.71K | Hold |
190
| – | – | ﹤0.01% | 571 |
|
|
2023
Q1 | $6.88K | Hold |
190
| – | – | ﹤0.01% | 496 |
|
|
2022
Q4 | $6.78K | Hold |
190
| – | – | ﹤0.01% | 479 |
|
|
2022
Q3 | $6K | Hold |
190
| – | – | ﹤0.01% | 507 |
|
|
2022
Q2 | $5K | Hold |
190
| – | – | ﹤0.01% | 578 |
|
|
2022
Q1 | $6K | Hold |
190
| – | – | ﹤0.01% | 541 |
|
|
2021
Q4 | $6K | Hold |
190
| – | – | ﹤0.01% | 575 |
|
|
2021
Q3 | $5K | Buy |
+190
| New | +$5K | ﹤0.01% | 584 |
|
|
2020
Q1 | – | Sell |
-190
| Closed | -$4K | – | 527 |
|
|
2019
Q4 | $4K | Buy |
+190
| New | +$4K | ﹤0.01% | 580 |
|